Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia

Back

ESC2025 Premium Access

Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia

Session: Lipids (3)

Topic: Lipids

Speaker: Doctor H. Tada (Kanazawa, JP)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Hayato Tada

Kanazawa University, Kanazawa (Japan)

3 presentations

0 follower

6 more presentations in this session

The effect of baseline prediabetes on the relation between lipoprotein (a) and incident type 2 diabetes and outcome: observations from the UK-Biobank.

Speaker: Doctor J. Sangha (Cambridge, GB)

Lipoprotein-(a) and mitral annular calcification: a systematic review and meta-analysis

Speaker: Doctor K. Kyriakoulis (Athens, GR)

Unmet needs of LDL C lowering in ACS patients when using only high intensity statins puts at setback

Speaker: Doctor S. Ramraika (Lucknow, IN)

Longitudinal impact of lipid levels on subclinical atherosclerosis in adolescents: insights from the LOOK study

Speaker: Doctor C. Abhayaratna (Sydney, AU)

The determinants of lack of atherosclerosis progression in adult patients with elevated lipoprotein(a). The results from the STAR-Lp(a) study.

Speaker: Professor M. Banach (Lodz, PL)

Access the full session

Lipids (3)

Speakers: Doctor H. Tada, Doctor J. Sangha, Doctor K. Kyriakoulis, Doctor S. Ramraika, Doctor C. Abhayaratna...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources